Zepbound is the first and only dual-activating GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) obesity medication
Acknowledgments We thank Home for Researchers (www.home-for-researchers.com) and Grammarly ( for their help with language
The regulatory environment for compounded GLP-1 medications continues to evolve, and consumers are encouraged to review the FDA's current public guidance on compounded GLP-1 products and to discuss treatment options with a qualified healthcare provider
This consultation will typically include: A review of your medical history, especially any history of medullary thyroid cancer (MTC), pancreatitis, or multiple endocrine neoplasia syndrome type 2 (MEN 2)
However, the total area under the curve (AUC), which represents overall drug exposure, remained comparable regardless of site
These medications work through multiple mechanisms: Delayed gastric emptying Reduced appetite Improved satiety Better insulin sensitivity Reduction in food cravings Improved glycemic control For many patients, especially those fearful of surgery, these medications appeared revolutionary